Assessment of MGMT Promoter Methylation in Advanced Ewing Sarcoma Treated With Temozolomide and Irinotecan
Clinical trial NCT03542097 · COMPLETED
Trial details
- NCT number
- NCT03542097
- Sponsor
- Istituto Ortopedico Rizzoli
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2014-04-15
- Primary completion
- 2018-12-31
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.